What is Summit Therapeutics Inc (SMMT)?
Summit Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for infectious diseases and rare genetic disorders. The company applies innovative approaches to address antibiotic resistance and other challenging medical conditions. Summit Therapeutics' pipeline includes product candidates targeting bacterial infections and Duchenne muscular dystrophy. The company engages in research collaborations and licensing agreements to advance its therapeutic programs. Its development strategy emphasizes the creation of differentiated medicines with potential to improve patient outcomes. Summit Therapeutics is headquartered in Oxford, United Kingdom, and operates with a commitment to advancing treatments through scientific innovation.
Summit Therapeutics Inc Stock Price Today: Live Overview
The price today is shaped by intraday trading activity, where Summit Therapeutics Inc is trading at $15.56. The price has ranged from $15.32 to $16.23, with a daily percentage change of 0%.
FAQ: Summit Therapeutics Inc (SMMT)
What is the current price of SMMT stock?
The price stands at $15.56.
Does SMMT pay dividends?
Summit Therapeutics Inc does not pay dividends.
Does SMMT have a formal corporate presence or regional headquarters in the UAE?
Summit Therapeutics Inc has no official presence in the UAE and operates via distributors.
What is SMMT best known for?
Summit Therapeutics Inc is most famous for its antibiotic development programs.
What assets are typically shown together with SMMT?
Commonly shown alongside SMMT: Neurocrine, Altimmune, Inc., Galectin Therapeutics Inc.
Latest shares articles



